fenofibrate has been researched along with Cancer of Lung in 5 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| " The additive inhibitory effect on cell proliferation by budesonide and fenofibrate combination suggests that the same or greater therapeutic effect could be achieved with reduced dosage and side effects when the two compounds are applied simultaneously." | 1.40 | Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors. ( Junco, JJ; Klug-De Santiago, HL; Kowalczyk, P; Liang, H; Malik, G; Slaga, TJ; Wei, SJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, MS | 1 |
| Han, QS | 1 |
| Jia, ZR | 1 |
| Chen, CS | 1 |
| Qiao, C | 1 |
| Liu, QQ | 1 |
| Zhang, YM | 1 |
| Wang, KW | 1 |
| Wang, J | 1 |
| Xiao, K | 1 |
| Ding, XS | 1 |
| Goncalves, MD | 1 |
| Hwang, SK | 1 |
| Pauli, C | 1 |
| Murphy, CJ | 1 |
| Cheng, Z | 1 |
| Hopkins, BD | 1 |
| Wu, D | 1 |
| Loughran, RM | 1 |
| Emerling, BM | 1 |
| Zhang, G | 1 |
| Fearon, DT | 1 |
| Cantley, LC | 1 |
| Liang, H | 1 |
| Kowalczyk, P | 1 |
| Junco, JJ | 1 |
| Klug-De Santiago, HL | 1 |
| Malik, G | 1 |
| Wei, SJ | 1 |
| Slaga, TJ | 1 |
| Kuno, T | 1 |
| Hata, K | 1 |
| Takamatsu, M | 1 |
| Hara, A | 1 |
| Hirose, Y | 1 |
| Takahashi, S | 1 |
| Imaida, K | 1 |
| Tanaka, T | 1 |
| Grabacka, M | 1 |
| Placha, W | 1 |
| Plonka, PM | 1 |
| Pajak, S | 1 |
| Urbanska, K | 1 |
| Laidler, P | 1 |
| Slominski, A | 1 |
5 other studies available for fenofibrate and Cancer of Lung
| Article | Year |
|---|---|
PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cel | 2022 |
Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
Topics: Amino Acids; Animals; Cachexia; Carcinoma, Non-Small-Cell Lung; Drug Evaluation, Preclinical; Fenofi | 2018 |
Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Blotting, Western; Budesonide; Cell Cycle; Cell Proliferat | 2014 |
The peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.
Topics: Animals; Cell Proliferation; Fenofibrate; Hyperlipidemias; Hypolipidemic Agents; Insulin; Insulin-Li | 2014 |
Inhibition of melanoma metastases by fenofibrate.
Topics: Animals; Antineoplastic Agents; Base Sequence; Cricetinae; Female; Fenofibrate; Hypolipidemic Agents | 2004 |